Detalles de la búsqueda
1.
Mllt11 Regulates Migration and Neurite Outgrowth of Cortical Projection Neurons during Development.
J Neurosci;
42(19): 3931-3948, 2022 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35379703
2.
Are Color Experiences the Same across the Visual Field?
J Cogn Neurosci;
35(4): 509-542, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36638234
3.
SPRY4-dependent ERK negative feedback demarcates functional adult stem cells in the male mouse germline.
Biol Reprod;
109(4): 533-551, 2023 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37552049
4.
Renal tubular transporter-mediated interactions between mirogabalin and cimetidine in rats.
Xenobiotica;
53(2): 114-122, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36715563
5.
Pharmacokinetic and pharmacodynamic assessment of histamine H3 receptor occupancy by enerisant: a human PET study with a novel H3 binding ligand, [11C]TASP457.
Eur J Nucl Med Mol Imaging;
49(4): 1127-1135, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34651222
6.
Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.
Eur J Clin Pharmacol;
78(1): 65-73, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34415382
7.
Functional robustness of adult spermatogonial stem cells after induction of hyperactive Hras.
PLoS Genet;
15(5): e1008139, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31050682
8.
Resting-state brain activity can predict target-independent aptitude in fMRI-neurofeedback training.
Neuroimage;
245: 118733, 2021 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34800664
9.
Dual orexin receptor antagonist (DORA-12) treatment affects the overall levels of Net/maoA mRNA expression in the hippocampus.
J Pharmacol Sci;
145(2): 198-201, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33451754
10.
Loss of tyrosine kinase receptor Ephb2 impairs proliferation and stem cell activity of spermatogonia in culture.
Biol Reprod;
102(4): 950-962, 2020 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31836902
11.
Drug-Drug Interaction Risk Assessment of Esaxerenone as a Perpetrator by In Vitro Studies and Static and Physiologically Based Pharmacokinetic Models.
Drug Metab Dispos;
48(9): 769-777, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32616542
12.
Critical Impact of Drug-Drug Interactions via Intestinal CYP3A in the Risk Assessment of Weak Perpetrators Using Physiologically Based Pharmacokinetic Models.
Drug Metab Dispos;
48(4): 288-296, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31996361
13.
Ziprasidone, a second-generation antipsychotic, affects core clock gene mRNA expression in mice.
J Pharmacol Sci;
144(1): 57-59, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32624301
14.
Biophysical Parameters of the Sec14 Phospholipid Exchange Cycle.
Biophys J;
116(1): 92-103, 2019 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30580923
15.
Pharmacokinetics, Metabolism, and Excretion of [14C]Esaxerenone, a Novel Mineralocorticoid Receptor Blocker in Humans.
Drug Metab Dispos;
47(3): 340-349, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30541878
16.
The influence of light sources on sunitinib measurements with photoisomerization.
Biomed Chromatogr;
33(2): e4407, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30315654
17.
In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, and Its Water-Soluble Prodrug, DS11960558, against Methicillin-Resistant Staphylococcus aureus.
Antimicrob Agents Chemother;
62(6)2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29610202
18.
In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, against Clostridium difficile.
Antimicrob Agents Chemother;
62(4)2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29439962
19.
Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report.
Int J Neuropsychopharmacol;
20(4): 285-294, 2017 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28031269
20.
Correction to: Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.
Eur J Clin Pharmacol;
78(1): 75, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34494163